Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Peripheral Arterial Disease Market?
The market size for peripheral arterial disease has experienced robust growth in the past few years. The market is predicted to grow from $4.36 billion in 2024 to $4.74 billion in 2025, with a compound annual growth rate (CAGR) of 8.7%. The historic growth can be linked to innovative medical devices, advancements in gene therapy and regenerative medicine, the development of pharmacogenomics, and the incorporation of digital health and remote monitoring.
The market size for peripheral arterial disease is anticipated to witness robust growth in the forthcoming years, reaching a value of $6.6 billion in 2029 with an 8.6% compound annual growth rate (CAGR). Factors such as interdisciplinary care teams, minimally invasive procedures, and lifestyle and exercise prescriptions attribute to this anticipated increase during the forecast period. Notably, the upcoming trends contributing to this growth involve vascular tele-rehabilitation, multimodal pain management, advancements in wound care, and public health promotions.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp
What Core Drivers Are Expected To Influence The Peripheral Arterial Disease Market?
The peripheral arterial disease market is seeing a surge due to the increasing rates of heart illnesses. These common heart conditions impact essential blood vessels that supply the heart and can be effectively treated through peripheral arterial disease treatments. These treatments not only improve blood flow but also reduce cardiovascular risk, provide relief from symptoms and enhance patients’ lives. For instance, The Australian Bureau of Statistics revealed in December 2023 that in 2022, 5.2% of the population, about 1.3 million people, suffered from heart, stroke, and vascular diseases. In the same vein, the American College of Cardiology disclosed in April 2022 that the risk factors for ischemic heart disease would likely escalate by 30.7%, affecting 29 million people by 2025. Thus, the increasing incidences of heart conditions fuel the growth of the peripheral arterial disease market.
What Are The Main Segment Classifications In The Peripheral Arterial Disease Market?
The peripheral arterial diseasemarket covered in this report is segmented –
1) By Treatment Type: Devices; Catheters; Drugs; Other Types
2) By Route of Administration: Oral; Parenteral; Other Route of Administrations
3) By End User: Hospitals; Specialty Clinics; Others End-Users
Subsegments:
1) By Devices: Stents; Balloons; Atherectomy Devices
2) By Catheters: Drug-Eluting Catheters; Balloon Catheters; Guidewires
3) By Drugs: Antiplatelet Agents; Anticoagulants; Vasodilators
4) By Other Types: Surgical Interventions; Lifestyle Modification Programs; Endovascular Therapy
Which Emerging Trends Are Reshaping The Peripheral Arterial Disease Market Landscape?
Leading businesses active in the peripheral arterial disease market are prioritizing the creation of novel medical apparatus like the intravascular lithotripsy (IVL) catheter. This move aims to enhance the effectiveness of treatment, improve the health outcomes for patients, and shorten the periods of recovery for those affected by vascular health conditions. IVL catheter, a type of medical equipment, is utilized to treat calcified obstructions in arteries by deploying controlled shockwaves to disintegrate the calcium, thereby aiding the restoration of blood circulation and increasing the vessel suppleness during procedures like angioplasty. A case in point is Shockwave Medical, Inc., a medical technology firm based in the U.S., which in September 2024, launched the Shockwave E8 peripheral IVL catheter. This medical device, designed for treating peripheral arterial disease, delivers targeted intravascular lithotripsy, employing sonic waves to dissolve calcium deposits in the artery walls. This innovative technique aids the revitalization of blood flow and minimizes damage to nearby tissues. The advanced design of this catheter aids easy movement through complex vascular anatomy, rendering it suitable for a diverse patient base.
Which Companies Are Contributing Significantly To The Peripheral Arterial Disease Market Growth?
Major companies operating in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report
Which Region Holds The Greatest Opportunity For Peripheral Arterial Disease Market Expansion?
North America was the largest region in the peripheral artery disease market in 2024. The regions covered in peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12999&type=smp
Browse Through More Reports Similar to the Global Peripheral Arterial Disease Market 2025, By The Business Research Company
Blood Transfusion Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Patient Blood Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Anemia And Other Blood Disorder Drugs Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
